For citations:
Tikhomirova T.T., Tyulyandina A.S., Rumyantsev A.A., Israelyan E.R., Kekeeva T.V., Vedrova O.V., Filipenko M.L., Lyubchenko L.N., Demidova I.A., Imyanitov E.N., Andreev S.Y., Khokhlova S.V., Saevets V.V., Statsenko G.B., Kolomiets L.A., Tkachenko S.A., Koroleva I.A., Lisyanskaya A.S., Bakashvili O.A., Krikunova L.I., Solovieva E.P., Ponomarenko D.M., Vladimirova L.Y., Krasilnikov S.E., Shirinkin V.B., Sakaeva D.D., Rumyantseva E.A., Emeliyanov S.A., Stroyakovskiy D.L., Novikova E.G., Ronina E.A., Vladimirov V.I., Novikova O.Y., Zagumennova L.S., Gorobtsova V.V., Cherepanova E.V., Pashkova E.N., Moiseyenko V.M., Ivanova F.G., Udovitsa D.P., Karaseva V.V., Tyulyandin S.A. BRCA-associated ovarian cancer in the russian patient population. Analysis of the non-interventional study Ovatar. Malignant tumours. 2023;13(4):46-59. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-4-46-59
Email this article 